XBIO
Xenetic Biosciences, Inc.
stockNASDAQ
At CloseNov 3, 2026 3:54:52 PM EST
2.03USD-1.699%(-0.03)11,455
XBIO Financials
In Q2 FY 2026 (ended ), Xenetic Biosciences, Inc. (XBIO) reported revenue of $660.6K, net income of −$929.7K, operating cash flow of −$875.49K, and assets of $6.97M.
Loading business breakdowns…